TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 18584575

Group type: EXPERIMENTAL
Intervention: Acamprosate
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Naltrexone
Number of subjects: 42

Group type: COMPARATOR
Intervention: Naltrexone and Acamprosate
Number of subjects: 42
Study: 16848265

Group type: EXPERIMENTAL
Intervention: Clearfil Protect Bond with round steel bur
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: OptiBond Solo Plus Total‐Etch with round steel bur
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Clearfil Protect Bond with silicon carbide abrasive paper
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: OptiBond Solo Plus Total‐Etch with silicon carbide abrasive paper
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Clearfil Protect Bond with Er:YAG laser
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: OptiBond Solo Plus Total‐Etch with Er:YAG laser
Number of subjects: 0
Study: 14635971

Group type: COMPARATOR
Intervention: Standard asthma care with information on the stepwise treatment approach, a written action plan, and inhaler technique training
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Additional structured allergen evaluation and avoidance advice
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Additional structured allergen evaluation and avoidance advice based on skin prick test results
Number of subjects: 54
Study: 10702178

Group type: EXPERIMENTAL
Intervention: Low-energy (LE) formula (419 kJ (100 kcal)*kg(‐)(1)*d(‐)(1))
Number of subjects: 36

Group type: COMPARATOR
Intervention: Normal-energy (NE) formula (502 kJ (80 kcal)*kg(‐)(1)*d(‐)(1))
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Low-energy (LE) formula
Number of subjects: 36

Group type: COMPARATOR
Intervention: Normal-energy (NE) formula
Number of subjects: 36
Study: 9429041

Group type: EXPERIMENTAL
Intervention: Intravenous PCA fentanyl
Number of subjects: 20

Group type: COMPARATOR
Intervention: Epidural analgesia
Number of subjects: 20
Study: 8397997

Group type: EXPERIMENTAL
Intervention: Enalaprilat (2.5 mg intravenously)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Saline placebo (control)
Number of subjects: 22
Study: 3301709

Group type: EXPERIMENTAL
Intervention: l(‐)ephedrine hydrochloride (50 mg three times a day per os)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 30071146

Group type: EXPERIMENTAL
Intervention: MOVING ON intervention
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control booklet
Number of subjects: 60
Study: 27289457

Group type: EXPERIMENTAL
Intervention: Conventional PENS of dermatome T6 with a 1200 kcal diet (group 1)
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: PENS of dermatome T6 with a self-applied patch associated with diet (group 2)
Number of subjects: 135

Group type: COMPARATOR
Intervention: 1200 kcal diet alone (group 3)
Number of subjects: 135
Study: 25071023

Group type: EXPERIMENTAL
Intervention: Exenatide (GLP-1 receptor agonist)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Exendin 9-39 (GLP-1 receptor blockade)
Number of subjects: 48
Study: 16402745

Group type: EXPERIMENTAL
Intervention: Comparative judgment task
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sequential recall or serial position identification task
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dichotomous categories on a linear order
Number of subjects: 0
Study: 12732401

Group type: EXPERIMENTAL
Intervention: Fenofibrate (200 mg/daily)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Coenzyme Q10 (200 mg/daily)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Fenofibrate plus Coenzyme Q10 (200+200 mg daily)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 9798024

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin (500 mg twice a day for 14 days)
Number of subjects: 307

Group type: COMPARATOR
Intervention: Cefuroxime axetil (500 mg twice a day for 14 days)
Number of subjects: 307

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin
Number of subjects: 307

Group type: COMPARATOR
Intervention: Cefuroxime axetil
Number of subjects: 307
Study: 8544592

Group type: EXPERIMENTAL
Intervention: 1% lidocaine with epinephrine at varying concentrations (1:400,000, 1:200,000, 1:100,000, 1:50,000)
Number of subjects: 23

Group type: COMPARATOR
Intervention: 1% lidocaine
Number of subjects: 23

Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 23
Study: 2349932

Group type: EXPERIMENTAL
Intervention: Aspartame (APM) sweetened soda (1150 g per day for 3 weeks)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: High-fructose corn syrup (HFCS) sweetened soda (1150 g per day for 3 weeks)
Number of subjects: 30
Study: 346541

Group type: EXPERIMENTAL
Intervention: Pentoxifyllin
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: Xantinol‐nicotinate
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: Betahistine
Number of subjects: 172

Group type: COMPARATOR
Intervention: Control (no medications)
Number of subjects: 172
Study: 30587225

Group type: EXPERIMENTAL
Intervention: 10 mg/kg doxycycline
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: 5 mg/kg doxycycline
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: 10 mg/kg minocycline
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: 5 mg/kg minocycline
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: 10 mg/kg doxycycline and minocycline
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: 5 mg/kg doxycycline and minocycline
Number of subjects: 32
Study: 27525966

Group type: COMPARATOR
Intervention: Vortioxetine (fixed-dose)
Number of subjects: 0

Group type: COMPARATOR
Intervention: HAM-D6
Number of subjects: 0

Group type: COMPARATOR
Intervention: HAM-D17, HAM-D21, HAM-D24
Number of subjects: 0
Study: 24326004

Group type: EXPERIMENTAL
Intervention: Glargine insulin delivery by pen device
Number of subjects: 31

Group type: COMPARATOR
Intervention: Glargine insulin delivery by vial/syringe
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Patient preference for insulin delivery method
Number of subjects: 31
Study: 22897098

Group type: EXPERIMENTAL
Intervention: Yoga
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Breath awareness
Number of subjects: 140

Group type: COMPARATOR
Intervention: Meditation music (comparison group)
Number of subjects: 140
Study: 19890262

Group type: EXPERIMENTAL
Intervention: Ketamine infusion (subanesthetic dose)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Saline infusion (placebo)
Number of subjects: 10
Study: 18477227

Group type: EXPERIMENTAL
Intervention: 2.5 mg/kg/day cyclosporin (CsA) treatment
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control group (healthy subjects)
Number of subjects: 27
Study: 16034820

Group type: EXPERIMENTAL
Intervention: Nutrition (intravenous glucose with amino acids)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Glucose only (intravenous glucose without amino acids)
Number of subjects: 16
Study: 12167548

Group type: EXPERIMENTAL
Intervention: Precipitated withdrawal using naloxone under anaesthetic
Number of subjects: 51

Group type: COMPARATOR
Intervention: Standard inpatient withdrawal treatment using clonidine plus symptomatic medication
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Precipitated withdrawal group
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Precipitated withdrawal under anesthesia
Number of subjects: 51
Study: 10361531

Group type: EXPERIMENTAL
Intervention: Average American diet (37% energy from fat, 17% saturated fat)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Step 1 diet (30% energy from fat, 10% saturated fat)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Low-saturated-fat diet (26% energy from fat, 6% saturated fat)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (not explicitly defined)
Number of subjects: 20
Study: 7555620

Group type: EXPERIMENTAL
Intervention: Carbamazepine 600 mg/day
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 2209499

Group type: EXPERIMENTAL
Intervention: 1.5 l Golytely preparation
Number of subjects: 50

Group type: COMPARATOR
Intervention: 3 l Golytely preparation
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: 1.5 l Golytely preparation (post-study routine)
Number of subjects: 50
Study: 7232842

Group type: EXPERIMENTAL
Intervention: Radiotherapy and chemotherapy
Number of subjects: 53

Group type: COMPARATOR
Intervention: Radiotherapy, chemotherapy, and MER
Number of subjects: 53
Study: 31661974

Group type: EXPERIMENTAL
Intervention: Combination treatment (N-acetylcysteine and mitochondrial agents)
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine
Number of subjects: 133

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Combination treatment
Number of subjects: 133
Study: 31109838

Group type: EXPERIMENTAL
Intervention: Antipsychotic drugs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cognitive behavioural therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of both
Number of subjects: 0
Study: 28319727

Group type: COMPARATOR
Intervention: No family witness
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Quiet family witness
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Distressed family witness
Number of subjects: 72
Study: 26386827

Group type: EXPERIMENTAL
Intervention: Buspirone (up to 60 mg/day)
Number of subjects: 175

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Buspirone
Number of subjects: 175
Study: 23751988

Group type: EXPERIMENTAL
Intervention: Hem-o-lok ligation system
Number of subjects: 53

Group type: COMPARATOR
Intervention: Endoloop ligature
Number of subjects: 53
Study: 21868284

Group type: EXPERIMENTAL
Intervention: Intraoperative MRI-guided surgery
Number of subjects: 58

Group type: COMPARATOR
Intervention: Conventional microsurgery (control group)
Number of subjects: 58
Study: 19454219

Group type: EXPERIMENTAL
Intervention: Generalized DNA random fragmentation model and quantitative PCR experiments using two different target sizes.
Number of subjects: 0
Study: 17904975

Group type: EXPERIMENTAL
Intervention: Selective fetoscopic laser photocoagulation (SFLP)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Serial amnioreduction (AR)
Number of subjects: 40
Study: 11773987

Group type: EXPERIMENTAL
Intervention: Verapamil SR/Trandolapril 180/2mg (VT)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Enalapril/Hydrochlorothiazide 20/12.5mg (EH)
Number of subjects: 93
Study: 12144330

Group type: EXPERIMENTAL
Intervention: Enrichment program (EP) with peer mentor/tutor (PMT) led study groups
Number of subjects: 0
Study: 9676035

Group type: EXPERIMENTAL
Intervention: G-CSF treatment
Number of subjects: 6

Group type: COMPARATOR
Intervention: Control subjects (no G-CSF treatment)
Number of subjects: 6
Study: 8063943

Group type: EXPERIMENTAL
Intervention: Examination of at least one random block of renal cortex during nephrectomy for primary renal cell carcinoma
Number of subjects: 0
Study: 3177585

Group type: EXPERIMENTAL
Intervention: Lenses with well rounded anterior edge profiles
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Rounded posterior edge profile
Number of subjects: 4

Group type: COMPARATOR
Intervention: Square anterior edge profiles
Number of subjects: 4
Study: 30305054

Group type: EXPERIMENTAL
Intervention: Paclitaxel plus bevacizumab (Arm B)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Paclitaxel alone (Arm A)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Bevacizumab treatment
Number of subjects: 51
Study: 28709739

Group type: EXPERIMENTAL
Intervention: 24-week lifestyle intervention (supervised aerobic exercise/Mediterranean diet)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group (25 age-matched healthy controls)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: 24-week lifestyle intervention
Number of subjects: 25
Study: 26248323

Group type: EXPERIMENTAL
Intervention: Ultrafast ultrasound imaging in healthy individuals
Number of subjects: 139

Group type: COMPARATOR
Intervention: Ultrafast ultrasound imaging in patients with vEDS
Number of subjects: 139
Study: 23788069

Group type: EXPERIMENTAL
Intervention: Patient-controlled analgesia (PCA)
Number of subjects: 350

Group type: COMPARATOR
Intervention: Patient education about PCA
Number of subjects: 350

Group type: EXPERIMENTAL
Intervention: Proposed PCA design features
Number of subjects: 350

Group type: COMPARATOR
Intervention: Uncertainty about receiving medicine when pushing the PCA button
Number of subjects: 350
Study: 21255195

Group type: EXPERIMENTAL
Intervention: Mianserin (20 mg; p.o.)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 18496261

Group type: EXPERIMENTAL
Intervention: Istaroxime 0.5 microg/kg/min
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Istaroxime 1.0 microg/kg/min
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Istaroxime 1.5 microg/kg/min
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 17147096

Group type: EXPERIMENTAL
Intervention: Alcohol (0.6% blood alcohol level)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Non-alcoholic beverage (control)
Number of subjects: 64
Study: 12713062

Group type: EXPERIMENTAL
Intervention: SQV-SGC 1200 mg three times daily plus two NRTIs
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: SQV-SGC 1600 mg twice daily plus two NRTIs
Number of subjects: 106

Group type: COMPARATOR
Intervention: SQV-SGC 1200 mg twice daily plus NFV 1250 mg twice daily plus one NRTI
Number of subjects: 106
Study: 10738041

Group type: EXPERIMENTAL
Intervention: Large-volume leukapheresis (LVL) with heparin
Number of subjects: 39

Group type: COMPARATOR
Intervention: Normal-volume leukapheresis (NVL)
Number of subjects: 39
Study: 8805090

Group type: EXPERIMENTAL
Intervention: d,l‐fenfluramine hydrochloride (60 mg orally)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 69
Study: 1637895

Group type: EXPERIMENTAL
Intervention: Prophylaxis therapy for pneumocystis carinii pneumonia
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High-dose 3-azido-3-deoxythymidine (AZT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low-dose 3-azido-3-deoxythymidine (AZT)
Number of subjects: 0
Study: 6706305

Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid (UDCA) at 2.1 mg X kg‐1 X day‐1
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid (UDCA) at 4.2 mg X kg‐1 X day‐1
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid (UDCA) at 8.4 mg X kg‐1 X day‐1
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid (UDCA) at 16.2 mg X kg‐1 X day‐1
Number of subjects: 197

Group type: COMPARATOR
Intervention: Chenodeoxycholic acid (CDCA) at 16.9 mg X kg‐1 X day‐1
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid (UDCA)
Number of subjects: 197

Group type: COMPARATOR
Intervention: Chenodeoxycholic acid (CDCA)
Number of subjects: 197
Study: 30266030

Group type: EXPERIMENTAL
Intervention: iCBT (internet-delivered cognitive behavioral therapy)
Number of subjects: 87

Group type: COMPARATOR
Intervention: TAU (treatment as usual)
Number of subjects: 87
Study: 29460201

Group type: EXPERIMENTAL
Intervention: Alfapump® system
Number of subjects: 60

Group type: COMPARATOR
Intervention: Large volume paracentesis (LVP)
Number of subjects: 60
Study: 26702629

Group type: EXPERIMENTAL
Intervention: SSTP + ACT
Number of subjects: 67

Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: SSTP
Number of subjects: 67
Study: 25190230

Group type: EXPERIMENTAL
Intervention: Patients with 0.1% to 1.5% ectopic beats
Number of subjects: 801

Group type: EXPERIMENTAL
Intervention: Patients with >1.5% ectopic beats
Number of subjects: 801

Group type: EXPERIMENTAL
Intervention: Patients with ≥0.1% ectopic beats
Number of subjects: 801
Study: 22709747

Group type: EXPERIMENTAL
Intervention: Vagus nerve stimulation using the CardioFit System (BioControl Medical, Yehud, Israel)
Number of subjects: 650

Group type: COMPARATOR
Intervention: Standard optimal medical therapy
Number of subjects: 650
Study: 20006197

Group type: EXPERIMENTAL
Intervention: ED-administered antibiotics
Number of subjects: 6476

Group type: EXPERIMENTAL
Intervention: IMPAACT intervention sites
Number of subjects: 6476

Group type: COMPARATOR
Intervention: Non-intervention sites
Number of subjects: 6476

Group type: EXPERIMENTAL
Intervention: 2003 to 2004
Number of subjects: 6476

Group type: EXPERIMENTAL
Intervention: 2004 to 2005
Number of subjects: 6476

Group type: EXPERIMENTAL
Intervention: 2005 to 2006
Number of subjects: 6476

Group type: EXPERIMENTAL
Intervention: 2006 to 2007
Number of subjects: 6476
Study: 17559725

Group type: EXPERIMENTAL
Intervention: Infliximab therapy for 6 weeks
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group (inactive patients)
Number of subjects: 12
Study: 15770833

Group type: EXPERIMENTAL
Intervention: Cefepime 150 mg/kg/day
Number of subjects: 50

Group type: COMPARATOR
Intervention: Ceftazidime 150 mg/kg/day + Amikacin 15 mg/kg/day
Number of subjects: 50
Study: 12390444

Group type: EXPERIMENTAL
Intervention: Cetirizine (0.25 mg/kg)
Number of subjects: 817

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 817

Group type: EXPERIMENTAL
Intervention: Cetirizine
Number of subjects: 817
Study: 9706857

Group type: EXPERIMENTAL
Intervention: Periodontal flap
Number of subjects: 10

Group type: COMPARATOR
Intervention: Gingivectomy
Number of subjects: 10
Study: 8110578

Group type: EXPERIMENTAL
Intervention: 2% lignocaine with 1:200,000 adrenaline at room temperature
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 2% lignocaine with 1:200,000 adrenaline at 38 degrees C
Number of subjects: 120

Group type: COMPARATOR
Intervention: 0.5% bupivacaine at room temperature
Number of subjects: 120

Group type: COMPARATOR
Intervention: 0.5% bupivacaine at 38 degrees C
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Warmed lignocaine
Number of subjects: 120

Group type: COMPARATOR
Intervention: All groups (including controls)
Number of subjects: 120
Study: 2804041

Group type: EXPERIMENTAL
Intervention: Anaesthetic technique based on spontaneous respiration
Number of subjects: 0

Group type: COMPARATOR
Intervention: Anaesthetic technique based on mechanical ventilation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Use of suxamethonium
Number of subjects: 0
Study: 819596

Group type: EXPERIMENTAL
Intervention: Human leukocyte interferon
Number of subjects: 49

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study: 7405925

Group type: EXPERIMENTAL
Intervention: Clindamycin
Number of subjects: 606

Group type: COMPARATOR
Intervention: Ampicillin
Number of subjects: 606

Group type: EXPERIMENTAL
Intervention: Clindamycin + Ampicillin
Number of subjects: 606

Group type: EXPERIMENTAL
Intervention: Post-antibiotic therapy
Number of subjects: 606
Study: 31502354

Group type: EXPERIMENTAL
Intervention: Mulligan's mobilization glides (3 sets of 10 repetitions)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham mobilization (therapist's hand over joint surfaces without gliding force)
Number of subjects: 30
Study: 31840969

Group type: EXPERIMENTAL
Intervention: Ocular cleansing with sterile gauze (group A) 3 times daily for 48 hours
Number of subjects: 63

Group type: COMPARATOR
Intervention: Ocular cleansing with Iridium® baby gauze containing Echinacea angustifolia (group B) 3 times daily for 48 hours
Number of subjects: 63
Study: 30083623

Group type: EXPERIMENTAL
Intervention: Telephone counseling intervention
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 64
Study: 26931422

Group type: EXPERIMENTAL
Intervention: Resistance Training (RT)
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Resistance Training plus Nutritional Supplementation (RTS)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Cognitive Training (CT)
Number of subjects: 91
Study: 24485665

Group type: EXPERIMENTAL
Intervention: PDT plus S-1
Number of subjects: 43

Group type: COMPARATOR
Intervention: PDT alone
Number of subjects: 43
Study: 23024190

Group type: EXPERIMENTAL
Intervention: Zoledronic acid (5 mg infusion)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Alendronate (70 mg weekly for 12 months)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Reference group (nonrandomized)
Number of subjects: 84
Study: 19602883

Group type: EXPERIMENTAL
Intervention: Subtle cognitive impairment (measured by MMSE)
Number of subjects: 172

Group type: COMPARATOR
Intervention: Control group (not specified intervention)
Number of subjects: 172
Study: 17558630

Group type: EXPERIMENTAL
Intervention: Ultrasonically nebulized distilled water (UNDW)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Ultrasonically nebulized distilled cold water (UDCW)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Methacholine
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Distilled cold water (DCW)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Distilled water
Number of subjects: 36
Study: 15221295

Group type: EXPERIMENTAL
Intervention: Gated SPECT with 99mTc‐sestamibi injection
Number of subjects: 241
Study: 12235452

Group type: EXPERIMENTAL
Intervention: Subcutaneous administration of enoxaparin (1.5 mg/kg once daily for 4 days)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Intravenous infusion of enoxaparin (1.5 mg/kg)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (nonobese volunteers)
Number of subjects: 48
Study: 9602765

Group type: EXPERIMENTAL
Intervention: Single dose radiotherapy of 5 Gy at the operation field preoperatively
Number of subjects: 57

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 57
Study: 7747098

Group type: EXPERIMENTAL
Intervention: Enhanced potency inactivated poliovirus vaccine (EIPV)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Oral poliovirus vaccine (OPV)
Number of subjects: 0
Study: 2564208

Group type: EXPERIMENTAL
Intervention: ICI 118,551
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 10
Study: 813297

Group type: EXPERIMENTAL
Intervention: Metacycline
Number of subjects: 69

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 69
Study: 31604814

Group type: EXPERIMENTAL
Intervention: Closed-loop acoustic stimulation during a daytime nap
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Closed-loop acoustic stimulation for word pairs
Number of subjects: 31
Study: 25850975

Group type: EXPERIMENTAL
Intervention: Simvastatin 40 mg daily
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Atorvastatin 20 mg daily
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 0